Argus Research Maintains Buy on Amgen, Raises Price Target to $310
Portfolio Pulse from Benzinga Newsdesk
Argus Research analyst David Toung maintains a 'Buy' rating on Amgen (NASDAQ:AMGN) and raises the price target from $280 to $310.
October 17, 2023 | 6:53 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Amgen's price target has been raised from $280 to $310 by Argus Research, which maintains a 'Buy' rating on the stock.
The raised price target and maintained 'Buy' rating by Argus Research indicates a positive outlook for Amgen. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100